192 related articles for article (PubMed ID: 38098230)
1. Blockade of C5a receptor unleashes tumor-associated macrophage antitumor response and enhances CXCL9-dependent CD8
Luan X; Lei T; Fang J; Liu X; Fu H; Li Y; Chu W; Jiang P; Tong C; Qi H; Fu Y
Mol Ther; 2024 Feb; 32(2):469-489. PubMed ID: 38098230
[TBL] [Abstract][Full Text] [Related]
2. Complement 5a stimulates macrophage polarization and contributes to tumor metastases of colon cancer.
Piao C; Zhang WM; Li TT; Zhang CC; Qiu S; Liu Y; Liu S; Jin M; Jia LX; Song WC; Du J
Exp Cell Res; 2018 May; 366(2):127-138. PubMed ID: 29551360
[TBL] [Abstract][Full Text] [Related]
3. The Complement Receptors C3aR and C5aR Are a New Class of Immune Checkpoint Receptor in Cancer Immunotherapy.
Wang Y; Zhang H; He YW
Front Immunol; 2019; 10():1574. PubMed ID: 31379815
[TBL] [Abstract][Full Text] [Related]
4. CXCL9-expressing tumor-associated macrophages: new players in the fight against cancer.
Marcovecchio PM; Thomas G; Salek-Ardakani S
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33637602
[TBL] [Abstract][Full Text] [Related]
5. Blocking LTB
Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
[TBL] [Abstract][Full Text] [Related]
6. Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade.
House IG; Savas P; Lai J; Chen AXY; Oliver AJ; Teo ZL; Todd KL; Henderson MA; Giuffrida L; Petley EV; Sek K; Mardiana S; Gide TN; Quek C; Scolyer RA; Long GV; Wilmott JS; Loi S; Darcy PK; Beavis PA
Clin Cancer Res; 2020 Jan; 26(2):487-504. PubMed ID: 31636098
[TBL] [Abstract][Full Text] [Related]
7. Complement C5a promotes antigen cross-presentation by Peyer's patch monocyte-derived dendritic cells and drives a protective CD8
Kim SH; Cho BH; Kim KS; Jang YS
Cell Rep; 2021 Apr; 35(2):108995. PubMed ID: 33852847
[TBL] [Abstract][Full Text] [Related]
8. M1
Garrido-Martin EM; Mellows TWP; Clarke J; Ganesan AP; Wood O; Cazaly A; Seumois G; Chee SJ; Alzetani A; King EV; Hedrick CC; Thomas G; Friedmann PS; Ottensmeier CH; Vijayanand P; Sanchez-Elsner T
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32699181
[TBL] [Abstract][Full Text] [Related]
9. Targeting complement C5a to improve radiotherapy sensitivity in non-small cell lung cancer.
Yuan M; Wang C; Wu Y; Qiao L; Deng G; Liang N; Chen F; Liu L; Chen Y; Yang Y; Wang H; Liu T; Yang X; Zhang Y; Lv Y; Suwinski R; Hu P; Zhang Y; Zhang J
Transl Lung Cancer Res; 2023 May; 12(5):1093-1107. PubMed ID: 37323177
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer C5a receptor expression and augmentation of cancer cell proliferation, invasion, and PD-L1 expression by C5a.
Imamura R; Kitagawa S; Kubo T; Irie A; Kariu T; Yoneda M; Kamba T; Imamura T
Prostate; 2021 Feb; 81(3):147-156. PubMed ID: 33368414
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological Polarization of Tumor-Associated Macrophages Toward a CXCL9 Antitumor Phenotype.
Enbergs N; Halabi EA; Goubet AG; Schleyer K; Fredrich IR; Kohler RH; Garris CS; Pittet MJ; Weissleder R
Adv Sci (Weinh); 2024 Apr; 11(15):e2309026. PubMed ID: 38342608
[TBL] [Abstract][Full Text] [Related]
12. YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8
Ma S; Sun B; Duan S; Han J; Barr T; Zhang J; Bissonnette MB; Kortylewski M; He C; Chen J; Caligiuri MA; Yu J
Nat Immunol; 2023 Feb; 24(2):255-266. PubMed ID: 36658237
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of human cancer cell motility and invasiveness by anaphylatoxin C5a via aberrantly expressed C5a receptor (CD88).
Nitta H; Wada Y; Kawano Y; Murakami Y; Irie A; Taniguchi K; Kikuchi K; Yamada G; Suzuki K; Honda J; Wilson-Morifuji M; Araki N; Eto M; Baba H; Imamura T
Clin Cancer Res; 2013 Apr; 19(8):2004-13. PubMed ID: 23287562
[TBL] [Abstract][Full Text] [Related]
14. Blockade of DC-SIGN
Hu B; Wang Z; Zeng H; Qi Y; Chen Y; Wang T; Wang J; Chang Y; Bai Q; Xia Y; Wang Y; Liu L; Zhu Y; Dai B; Guo J; Xu L; Zhang W; Xu J
Cancer Res; 2020 Apr; 80(8):1707-1719. PubMed ID: 32060149
[TBL] [Abstract][Full Text] [Related]
15. Vinblastine resets tumor-associated macrophages toward M1 phenotype and promotes antitumor immune response.
Wang YN; Wang YY; Wang J; Bai WJ; Miao NJ; Wang J
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37652576
[TBL] [Abstract][Full Text] [Related]
16. Targeting OXCT1-mediated ketone metabolism reprograms macrophages to promote antitumor immunity via CD8
Zhu CX; Yan K; Chen L; Huang RR; Bian ZH; Wei HR; Gu XM; Zhao YY; Liu MC; Suo CX; Li ZK; Yang ZY; Lu MQ; Hua XF; Li L; Zhao ZB; Sun LC; Zhang HF; Gao P; Lian ZX
J Hepatol; 2024 May; ():. PubMed ID: 38759889
[TBL] [Abstract][Full Text] [Related]
17. Complement receptor C5aR1 blockade reprograms tumor-associated macrophages and synergizes with anti-PD-1 therapy in gastric cancer.
Zhang P; Gu Y; Wang J; Lv K; Lin C; Zhang H; Li H; He H; Li R; Liu H; Xu J
Int J Cancer; 2023 Jul; 153(1):224-237. PubMed ID: 36799619
[TBL] [Abstract][Full Text] [Related]
18. Complement c5a receptor facilitates cancer metastasis by altering T-cell responses in the metastatic niche.
Vadrevu SK; Chintala NK; Sharma SK; Sharma P; Cleveland C; Riediger L; Manne S; Fairlie DP; Gorczyca W; Almanza O; Karbowniczek M; Markiewski MM
Cancer Res; 2014 Jul; 74(13):3454-65. PubMed ID: 24786787
[TBL] [Abstract][Full Text] [Related]
19. Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity.
Abe S; Nagata H; Crosby EJ; Inoue Y; Kaneko K; Liu CX; Yang X; Wang T; Acharya CR; Agarwal P; Snyder J; Gwin W; Morse MA; Zhong P; Lyerly HK; Osada T
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35039461
[TBL] [Abstract][Full Text] [Related]
20. Autocrine Complement Inhibits IL10-Dependent T-cell-Mediated Antitumor Immunity to Promote Tumor Progression.
Wang Y; Sun SN; Liu Q; Yu YY; Guo J; Wang K; Xing BC; Zheng QF; Campa MJ; Patz EF; Li SY; He YW
Cancer Discov; 2016 Sep; 6(9):1022-35. PubMed ID: 27297552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
